Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.
Matuschek C, Bölke E, Belka C, Ganswindt U, Henke M, Stegmaier P, Bamberg M, Welz S, Debus J, Gioules A, Voigt A, Volk G, Ohmann C, Wiegel T, Budach V, Stuschke M, Schipper J, Gerber PA, Budach W.
Matuschek C, et al. Among authors: budach w, budach v.
Strahlenther Onkol. 2013 Aug;189(8):625-31. doi: 10.1007/s00066-013-0378-2. Epub 2013 Jul 5.
Strahlenther Onkol. 2013.
PMID: 23824104
Clinical Trial.